Insulin-like growth factor-1 is associated with regulation of the luteinizing hormone production in men receiving androgen deprivation therapy with gonadotropin-releasing hormone analogues for localized prostate cancer. [electronic resource]
Producer: 20130405Description: 596-601 p. digitalISSN:- 1873-2496
- Adrenocorticotropic Hormone -- blood
- Aged
- Androgen Antagonists -- administration & dosage
- Antineoplastic Agents, Hormonal -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Dehydroepiandrosterone Sulfate -- blood
- Flutamide -- administration & dosage
- Goserelin -- administration & dosage
- Human Growth Hormone -- blood
- Humans
- Immunoassay -- methods
- Insulin-Like Growth Factor I -- metabolism
- Logistic Models
- Luteinizing Hormone -- blood
- Male
- Middle Aged
- Multivariate Analysis
- Outcome Assessment, Health Care
- Prospective Studies
- Prostate-Specific Antigen -- blood
- Prostatic Neoplasms -- blood
- Testosterone -- blood
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.